[HTML][HTML] One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison

RR Bahadoer, E Bastiaannet, YHM Claassen… - European Journal of …, 2021 - Elsevier
Background Mortality in the first postoperative year represents an accurate reflection of the
perioperative risk after colorectal cancer surgery. This research compares one-year mortality …

Neoadjuvant radiation for cutaneous and soft tissue angiosarcoma

CE Sharon, RJ Straker, AB Shannon… - Journal of Surgical …, 2022 - Wiley Online Library
Abstract Background and Objectives Neoadjuvant radiation (NRT) is frequently utilized in
soft tissue sarcomas to increase local control. Its utility in cutaneous and soft tissue …

Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II …

Y Chang, X Zhao, Y Xiao, S Yan, W Xu, Y Wang… - Frontiers of …, 2023 - Springer
To evaluate the safety and efficacy of neoadjuvant radiohormonal therapy for oligometastatic
prostate cancer (OMPC), we conducted a 3+ 3 dose escalation, prospective, phase I/II …

Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: A systematic review and meta-analysis

J He, S Wang, P Liu - British Journal of Radiology, 2024 - academic.oup.com
Objectives To evaluate the performance of machine learning models in predicting treatment
response to neoadjuvant chemoradiotherapy (nCRT) in rectal cancer using computed …

Regional variance in treatment and outcomes of locally invasive (T4) rectal cancer in Australia and New Zealand: analysis of the Bi‐National Colorectal Cancer Audit

TL Dinger, HM Kroon, L Traeger… - ANZ Journal of …, 2022 - Wiley Online Library
Backgrounds Locally invasive T4 rectal cancer often requires neoadjuvant treatment
followed by multi‐visceral surgery to achieve a radical resection (R0), and referral to a …

[HTML][HTML] Can lymphocytes serve as a predictor of response to preoperative chemoradiation therapy for locally advanced rectal cancer?

M Lutsyk, T Taha, S Billan - Frontiers in Oncology, 2023 - frontiersin.org
Introduction: The aim of this study is to identify factors that may predict the response of
locally advanced rectal cancer tumors (LARC) to neoadjuvant chemoradiotherapy (CRT) …

[HTML][HTML] The influence of predictive nursing on the emotions and self-management abilities of post-colostomy rectal cancer patients

L Li, L Liu, H Kang, L Zhang - American Journal of Translational …, 2021 - ncbi.nlm.nih.gov
Objective: This study aimed to explore the influence of predictive nursing on the emotions
and self-management abilities of post-colostomy rectal cancer patients. Methods: From …

A predictive nomogram model for low anterior resection syndrome after Rectal cancer resection

M Yan, Z Lin, Z Wu, H Zheng, M Shi - ANZ Journal of Surgery, 2022 - Wiley Online Library
Background The aim of this study was to identify risk factors associated with the low anterior
resection syndrome (LARS) and to construct a nomogram capable of predicting the risk of …

C-reactive protein as predictive biomarker for response to chemoradiotherapy in patients with locally advanced rectal cancer: a retrospective study

F Aires, D Rodrigues, MP Lamas, MT Herdeiro… - Cancers, 2022 - mdpi.com
Simple Summary Most patients with locally advanced rectal cancer present resistance or a
moderate response to neoadjuvant chemoradiotherapy (nCRT), which is considered the …

Scenario of Rectal Carcinoma Cases in a Rural Setting of Central India.

D Tote, R Domakunti, S Tote - Journal of Evolution of Medical and …, 2020 - go.gale.com
BACKGROUND Rectal cancer ranks second in the list of common cancers (28%) in large
intestine. Curative surgical resection is the treatment of choice for patients of carcinoma …